Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
17(17):5774-82
is a novel naphthalimide that binds to DNA by intercalation and suppresses CXCL chemokine elaboration
is a novel glycine antagonist of NMDA receptor activation
AC-55541 was well absorbed when administered intraperitoneally to rats
but not H3K56ac as revealed by western blot analysis
GDC-0449 (Vismodegib) - Hedgehog Antagonist. CAS# 879085-55-9 094 17(17):5774-82Vismodegib (GDC 0449), CAS No. 879085 55 9, is a potent and specific hedgehog pathway inhibitor with an IC50 of 3 nM. It has been approved by FDA to treat BCC, and also in multiple clinical trials to treat advanced solid tumors. It blocks the activities of the Hedgehog ligand cell surface receptors PTCH and or SMO and suppressing Hedgehog signaling. It prevents multiple ATP binding cassette (ABC) transporters. GDC 0449 also exhibited efficacy in